Prc contributes to Escherichia coli evasion of classical complement-mediated serum killing

Infection and Immunity

Volumn 80, Issue 10, 2012, Pages 3399-3409

  Wang, Chin Ya ^a   Wang, Shainn Wei ^a   Huang, Wen Chun ^a   Kim, Kwang Sik ^b   Chang, Nan Shan ^a   Wang, Ying Hsiang ^c,d   Wu, Meng Hsing ^a   Teng, Ching Hao ^a,e  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PERIPLASMIC PROTEIN;

ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTEREMIA; BACTERIAL OUTER MEMBRANE PROTEINS; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; ENDOPEPTIDASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MUTATION; RABBITS;

EID: 84867585282     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00321-12     Document Type: Article

References (49)

1. Abdullah M, et al. 2005. Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding. Infect. Immun. 73:3431-3439.
2. Achtman M, et al. 1983. Six widespread bacterial clones among Escherichia coli K1 isolates. Infect. Immun. 39:315-335.
3. Bandara AB, et al. 2008. A disruption of ctpA encoding carboxy-terminal protease attenuates Burkholderia mallei and induces partial protection in CD1 mice. Microb. Pathog. 45:207-216.
4. Bandara AB, Sriranganathan N, Schurig GG, Boyle SM. 2005. Carboxylterminal protease regulates Brucella suis morphology in culture and persistence in macrophages and mice. J. Bacteriol. 187:5767-5775.
5. Baumler AJ, Kusters JG, Stojiljkovic I, Heffron F. 1994. Salmonella typhimurium loci involved in survival within macrophages. Infect. Immun. 62:1623-1630.
6. Beebe KD, Pei D. 1998. A continuous fluorimetric assay for tail-specific protease. Anal. Biochem. 263:51-56.
7. Beebe KD, et al. 2000. Substrate recognition through a PDZ domain in tail-specific protease. Biochemistry 39:3149 -3155.
8. Bowe F, et al. 1998. At least four percent of the Salmonella typhimurium genome is required for fatal infection of mice. Infect. Immun. 66:3372- 3377.
9. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
10. Fanning AS, Anderson JM. 1996. Protein-protein interactions: PDZ domain networks. Curr. Biol. 6:1385-1388.
11. Fields PI, Swanson RV, Haidaris CG, Heffron F. 1986. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc. Natl. Acad. Sci. U. S. A. 83:5189 -5193.
12. Fognini-Lefebvre N, Lazzaroni JC, Portalier R. 1987. tolA, tolB and excC, three cistrons involved in the control of pleiotropic release of periplasmic proteins by Escherichia coli K12. Mol. Gen. Genet. 209:391-395.
13. Fomsgaard A, Freudenberg MA, Galanos C. 1990. Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels. J. Clin. Microbiol. 28:2627-2631.
14. Gaspar JA, Thomas JA, Marolda CL, Valvano MA. 2000. Surface expression of O-specific lipopolysaccharide in Escherichia coli requires the function of the TolA protein. Mol. Microbiol. 38:262-275.
15. Godlewska R, Wisniewska K, Pietras Z, Jagusztyn-Krynicka EK. 2009. Peptidoglycan-associated lipoprotein (Pal) of Gram-negative bacteria: function, structure, role in pathogenesis and potential application in immunoprophylaxis. FEMS Microbiol. Lett. 298:1-11.
16. Hara H, Yamamoto Y, Higashitani A, Suzuki H, Nishimura Y. 1991. Cloning, mapping, and characterization of the Escherichia coli prc gene, which is involved in C-terminal processing of penicillin-binding protein 3. J. Bacteriol. 173:4799-4813.
17. Herpers BL, et al. 2009. Hemolytic assay for the measurement of functional human mannose-binding lectin: a modification to avoid interference from classical pathway activation. J. Immunol. Methods 343:61- 63.
18. Ikeda F, et al. 1998. Human complement component C1q inhibits the infectivity of cell-free HTLV-I. J. Immunol. 161:5712-5719.
19. Kariyawasam S, Wilkie BN, Hunter DB, Gyles CL. 2002. Systemic and mucosal antibody responses to selected cell surface antigens of avian pathogenic Escherichia coli in experimentally infected chickens. Avian Dis. 46:668-678.
20. Keiler KC, Sauer RT. 1995. Identification of active site residues of the Tsp protease. J. Biol. Chem. 270:28864 -28868.
21. Keiler KC, Sauer RT. 1996. Sequence determinants of C-terminal substrate recognition by the Tsp protease. J. Biol. Chem. 271:2589 -2593.
22. Keiler KC, et al. 1995. C-terminal specific protein degradation: activity and substrate specificity of the Tsp protease. Protein Sci. 4:1507-1515.
23. Kim KS. 2001. Escherichia coli translocation at the blood-brain barrier. Infect. Immun. 69:5217-5222.
24. Kim KS. 2003. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat. Rev. Neurosci. 4:376 -385.
25. Lazzaroni JC, Portalier R. 1992. The excC gene of Escherichia coli K-12 required for cell envelope integrity encodes the peptidoglycan-associated lipoprotein (PAL). Mol. Microbiol. 6:735-742.
26. Lerner CG, Inouye M. 1990. Low copy number plasmids for regulated low-level expression of cloned genes in Escherichia coli with blue/white insert screening capability. Nucleic Acids Res. 18:4631. doi:10.1093/nar/ 18.15.4631.
27. Lloyd AL, Smith SN, Eaton KA, Mobley HL. 2009. Uropathogenic Escherichia coli suppresses the host inflammatory response via pathogenicity island genes sisA and sisB. Infect. Immun. 77:5322-5333.
28. MacKay SL, Dankert JR. 1990. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites. J. Immunol. 145:3367-3371.
29. Matsumoto M, et al. 1997. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. U. S. A. 94:8720-8725.
30. Paterson GK, et al. 2009. Deletion of tolA in Salmonella Typhimurium generates an attenuated strain with vaccine potential. Microbiology 155: 220-228.
31. Petersen SV, et al. 2000. Control of the classical and the MBL pathway of complement activation. Mol. Immunol. 37:803- 811.
32. Pluschke G, Mayden J, Achtman M, Levine RP. 1983. Role of the capsule and theOantigen in resistance of O18:K1 Escherichia coli to complement mediated killing. Infect. Immun. 42:907-913.
33. Prasadarao NV, Blom AM, Villoutreix BO, Linsangan LC. 2002. A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. J. Immunol. 169:6352- 6360.
34. Quaas R, Landt O, Grunert HP, Beineke M, Hahn U. 1989. Indicator plates for rapid detection of ribonuclease T1 secreting Escherichia coli clones. Nucleic Acids Res. 17:3318. doi:10.1093/nar/17.8.3318.
35. Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 5:449-456.
36. Seoane A, Sabbaj A, McMurry LM, Levy SB. 1992. Multiple antibiotic susceptibility associated with inactivation of the prc gene. J. Bacteriol. 174:7844 -7847.
37. Silber KR, Keiler KC, Sauer RT. 1992. Tsp: a tail-specific protease that selectively degrades proteins with nonpolar C termini. Proc. Natl. Acad. Sci. U. S. A. 89:295-299.
38. Silver RP, Aaronson W, Sutton A, Schneerson R. 1980. Comparative analysis of plasmids and some metabolic characteristics of Escherichia coli K1 from diseased and healthy individuals. Infect. Immun. 29:200 -206.
39. Spiers A, et al. 2002. PDZ domains facilitate binding of high temperature requirement protease A (HtrA) and tail-specific protease (Tsp) to heterologous substrates through recognition of the small stable RNA A (ssrA)-encoded peptide. J. Biol. Chem. 277:39443-39449.
40. Stoop JW, Zegers BJ, Sander PC, Ballieux RE. 1969. Serum immunoglobulin levels in healthy children and adults. Clin. Exp. Immunol. 4:101- 112.
41. Sturgis JN. 2001. Organisation and evolution of the tol-pal gene cluster. J. Mol. Microbiol. Biotechnol. 3:113-122.
42. Tadokoro A, et al. 2004. Interaction of the Escherichia coli lipoprotein NlpI with periplasmic Prc (Tsp) protease. J. Biochem. 135:185-191.
43. Teng CH, et al. 2010. NlpI contributes to Escherichia coli K1 strain RS218 interaction with human brain microvascular endothelial cells. Infect. Immun. 78:3090 -3096.
44. Vermeulen C, Cross A, Byrne WR, Zollinger W. 1988. Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli. Infect. Immun. 56:2723-2730.
45. Walport MJ. 2001. Complement. First of two parts. N. Engl. J. Med. 344:1058 -1066.
46. Warren L. 1959. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234:1971-1975.
47. Webster RE. 1991. The tol gene products and the import of macromolecules into Escherichia coli. Mol. Microbiol. 5:1005-1011.
48. Wright SD, Levine RP. 1981. How complement kills E. coli. I. Location of the lethal lesion. J. Immunol. 127:1146 -1151.
49. Xie Y, Yao Y, Kolisnychenko V, Teng CH, Kim KS. 2006. HbiF regulates type 1 fimbriation independently of FimB and FimE. Infect. Immun. 74: 4039-4047.